Correlation Between PennyMac Finl and Werewolf Therapeutics
Can any of the company-specific risk be diversified away by investing in both PennyMac Finl and Werewolf Therapeutics at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining PennyMac Finl and Werewolf Therapeutics into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between PennyMac Finl Svcs and Werewolf Therapeutics, you can compare the effects of market volatilities on PennyMac Finl and Werewolf Therapeutics and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in PennyMac Finl with a short position of Werewolf Therapeutics. Check out your portfolio center. Please also check ongoing floating volatility patterns of PennyMac Finl and Werewolf Therapeutics.
Diversification Opportunities for PennyMac Finl and Werewolf Therapeutics
-0.09 | Correlation Coefficient |
Good diversification
The 3 months correlation between PennyMac and Werewolf is -0.09. Overlapping area represents the amount of risk that can be diversified away by holding PennyMac Finl Svcs and Werewolf Therapeutics in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Werewolf Therapeutics and PennyMac Finl is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on PennyMac Finl Svcs are associated (or correlated) with Werewolf Therapeutics. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Werewolf Therapeutics has no effect on the direction of PennyMac Finl i.e., PennyMac Finl and Werewolf Therapeutics go up and down completely randomly.
Pair Corralation between PennyMac Finl and Werewolf Therapeutics
Given the investment horizon of 90 days PennyMac Finl Svcs is expected to generate 0.34 times more return on investment than Werewolf Therapeutics. However, PennyMac Finl Svcs is 2.92 times less risky than Werewolf Therapeutics. It trades about -0.12 of its potential returns per unit of risk. Werewolf Therapeutics is currently generating about -0.14 per unit of risk. If you would invest 10,564 in PennyMac Finl Svcs on October 5, 2024 and sell it today you would lose (350.00) from holding PennyMac Finl Svcs or give up 3.31% of portfolio value over 90 days.
Time Period | 3 Months [change] |
Direction | Moves Against |
Strength | Insignificant |
Accuracy | 100.0% |
Values | Daily Returns |
PennyMac Finl Svcs vs. Werewolf Therapeutics
Performance |
Timeline |
PennyMac Finl Svcs |
Werewolf Therapeutics |
PennyMac Finl and Werewolf Therapeutics Volatility Contrast
Predicted Return Density |
Returns |
Pair Trading with PennyMac Finl and Werewolf Therapeutics
The main advantage of trading using opposite PennyMac Finl and Werewolf Therapeutics positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if PennyMac Finl position performs unexpectedly, Werewolf Therapeutics can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Werewolf Therapeutics will offset losses from the drop in Werewolf Therapeutics' long position.PennyMac Finl vs. Encore Capital Group | PennyMac Finl vs. Greystone Housing Impact | PennyMac Finl vs. Guild Holdings Co | PennyMac Finl vs. Security National Financial |
Werewolf Therapeutics vs. Monte Rosa Therapeutics | Werewolf Therapeutics vs. Design Therapeutics | Werewolf Therapeutics vs. Ikena Oncology | Werewolf Therapeutics vs. Stoke Therapeutics |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Funds Screener module to find actively-traded funds from around the world traded on over 30 global exchanges.
Other Complementary Tools
Portfolio Backtesting Avoid under-diversification and over-optimization by backtesting your portfolios | |
Theme Ratings Determine theme ratings based on digital equity recommendations. Macroaxis theme ratings are based on combination of fundamental analysis and risk-adjusted market performance | |
Portfolio Anywhere Track or share privately all of your investments from the convenience of any device | |
Global Markets Map Get a quick overview of global market snapshot using zoomable world map. Drill down to check world indexes | |
Equity Search Search for actively traded equities including funds and ETFs from over 30 global markets |